Unicycive Therapeutics Stock (NASDAQ: UNCY) stock price, news, charts, stock research, profile.
You can purchase shares of Unicycive Therapeutics (NASDAQ:UNCY) through any online brokerage.
Other companies in Unicycive Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Estrella Immunopharma (NASDAQ:ESLA), bluebird bio (NASDAQ:BLUE), Gain Therapeutics (NASDAQ:GANX) and Immuneering (NASDAQ:IMRX).
Unicycive Therapeutics has a consensus price target of $5.50.
The stock price for Unicycive Therapeutics (NASDAQ: UNCY) is $0.6199 last updated February 21, 2025 at 5:50 PM EST.
There are no upcoming dividends for Unicycive Therapeutics.
Unicycive Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Unicycive Therapeutics.
Unicycive Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.